Appointments: Bayer, Biogen, BTG, Shire, Immodulon Therapeutics, Neurocrine Biosciences
Executive Summary
The week's round-up includes new CFOs at Shire and BTG and Neurocrine Biosciences, a new CEO at Gamida Cell, a new general counsel at Scynexis, and a new head for Bayer's consumer health division.